Skip to main content
. 2021 Sep 6;137(5):929–935. doi: 10.1177/00333549211041545

Table 3.

Changes in living situation from admission to discharge among adults hospitalized with laboratory-confirmed respiratory syncytial virus infection, October 2017 through April 2018 and October 2018 through April 2019, New York City a

Change from admission to discharge b Total, no. (%) (n = 372) c Severe clinical outcomes
No, no. (%) (n = 325) Yes, no. (%) (n = 47) Odds ratio (95% CI) P value
Unchanged: Level 1 127 (34.1) 117 (36.0) 10 (21.3) 0.48 (0.23-1.00) .05
Unchanged: Level 2 156 (41.9) 146 (44.9) 10 (21.3) 0.33 (0.16-0.69) .003
Unchanged: Level 3 30 (8.1) 19 (5.8) 11 (23.4) 4.92 (2.17-11.16) <.001
Increased: Level 1 to Level 2 20 (5.4) 17 (5.2) 3 (6.4) 1.24 (0.35-4.39) .73
Increased: Level 1 to Level 3 12 (3.2) 7 (2.2) 5 (10.6) 5.41 (1.64-17.81) .005
Increased: Level 2 to Level 3 24 (6.5) 17 (5.2) 7 (14.9) 3.17 (1.24-8.12) .02
Any increase in level of care 56 (15.1) 41 (12.6) 15 (31.9) 3.25 (1.62-6.51) .001
Any decrease in level of care 3 (0.8) 2 (0.6) 1 (2.1) 3.51 (0.31-39.49) .33

aData were extracted by the research team from the electronic medical records of 3 academically affiliated hospitals in northern Manhattan.

bLevel 1, independent; Level 2, assistance of family, friends, or home health aide; Level 3, assisted living, skilled nursing or long-term care facility, rehabilitation facility, or hospice.

cAnalysis included 372 surviving patients. Excluded patients included 1 patient who was homeless at admission, 3 patients discharged to another acute care facility, and 27 patients who died.